  See all
 |
Articles: Hepatobiliary/Pancreas |
Prior Articles
MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease
Cancer Prevention Research, 09/16/09
CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection
BMC Cancer, 09/15/09
Free full text
Induction of Bim Expression Contributes to the Antitumor Synergy Between Sorafenib and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Inhibitor CI-1040 in Hepatocellular Carcinoma
Clinical Cancer Research, 09/15/09
Exclusive Author Commentary Serine Protease Inhibitor Kazal Type 1 Promotes Proliferation of Pancreatic Cancer Cells through the Epidermal Growth Factor Receptor
Molecular Cancer Research, 09/15/09 A Multi-Institutional Phase II Study of the Efficacy and Tolerability of Lapatinib in Patients with Advanced Hepatocellular Carcinomas
Clinical Cancer Research, 09/14/09 Are Racial Disparities in Pancreatic Cancer Explained by Smoking and Overweight/Obesity
Cancer Epidemiology, Biomarkers & Prevention, 09/14/09 Serum Fatty Acid Synthase as a Marker of Pancreatic Neoplasia
Cancer Epidemiology, Biomarkers & Prevention, 09/14/09 Polymorphic Variants in Hereditary Pancreatic Cancer Genes Are Not Associated with Pancreatic Cancer Risk
Cancer Epidemiology, Biomarkers & Prevention, 09/14/09 Carcinosarcoma of pancreas with liver metastasis combined with gastrointestinal stromal tumour of the stomach: is there a good prognosis with the complete resection
European Journal of Cancer Care, 09/11/09 Pancreatic cancers initial presentation: back pain due to osteoblastic bone metastasis
European Journal of Cancer Care, 09/11/09 Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma
European Journal of Cancer Care, 09/11/09 Occult hepatocellular carcinoma: a case report of a special icteric-type hepatoma and literature review
European Journal of Cancer Care, 09/10/09 Duodeno-pancreatic neuroendocrine tumours
European Journal of Cancer Care, 09/09/09 Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment?
Oncology (Karger), 09/08/09 CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
Clinical Cancer Research, 09/08/09 Decreased Blood Flow with Increased Metabolic Activity: A Novel Sign of Pancreatic Tumor Aggressiveness
Clinical Cancer Research, 09/08/09 Intraductal tubular adenoma (pyloric gland-type) of the pancreas: a reappraisal and possible relationship with gastric-type intraductal papillary mucinous neoplasm
Histopathology, 09/04/09 Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1mm of a resection margin
Histopathology, 09/04/09 Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
The Lancet Oncology - Online First, 09/03/09 CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone
British Journal of Cancer, 09/03/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
